- All sections
- C - Chemistry; metallurgy
- C07D - Heterocyclic compounds
- C07D 519/00 - Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups or
Patent holdings for IPC class C07D 519/00
Total number of patents in this class: 7500
10-year publication summary
|
428
|
529
|
524
|
614
|
631
|
651
|
740
|
804
|
907
|
304
|
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Bristol-myers Squibb Company | 5080 |
172 |
| Hoffmann-La Roche Inc. | 3060 |
141 |
| Merck Sharp & Dohme LLC | 3689 |
139 |
| F. Hoffmann-La Roche AG | 7958 |
133 |
| Incyte Corporation | 918 |
121 |
| Gilead Sciences, Inc. | 1879 |
117 |
| Merck Patent GmbH | 5909 |
116 |
| Janssen Pharmaceutica N.V. | 3839 |
112 |
| Genentech, Inc. | 3742 |
106 |
| Takeda Pharmaceutical Company Limited | 2961 |
106 |
| Boehringer Ingelheim International GmbH | 4629 |
100 |
| Pfizer Inc. | 3322 |
97 |
| Novartis AG | 11238 |
74 |
| Array BioPharma Inc. | 551 |
70 |
| ImmunoGen, Inc. | 405 |
61 |
| Idemitsu Kosan Co., Ltd. | 3995 |
60 |
| Amgen Inc. | 3779 |
57 |
| Medshine Discovery Inc. | 581 |
52 |
| Bayer Pharma AG | 1096 |
50 |
| Taisho Pharmaceutical Co., Ltd. | 844 |
49 |
| Other owners | 5567 |